Financhill
Back

Vir Biotechnology Quote, Financials, Valuation and Earnings

Vir Biotechnology Price Quote

$10.39

Vir Biotechnology Key Stats

Buy
65
Vir Biotechnology (VIR) is a Buy

Day range:
$10.02 - $10.59
52-week range:
$7.61 - $27.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
35.29
P/B ratio:
0.88%

Volume:
1.7M
Avg. volume:
883K
1-year change:
-59.08%
Market cap:
$1.4B
Revenue:
$39.5M
EPS:
$-4.59

How Much Does Vir Biotechnology Make?

Is Vir Biotechnology Growing As A Company?

  • What Is Vir Biotechnology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.56%
  • What Is Vir Biotechnology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Vir Biotechnology Stock Price Performance

  • Did Vir Biotechnology Stock Go Up Last Month?
    Vir Biotechnology share price went up by 7.22% last month
  • Did VIR's Share Price Rise Over The Last Year?
    VIR share price fell by -59.08% over the past 1 year

What Is Vir Biotechnology 52-Week High & Low?

Vir Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vir Biotechnology?

  • How Much Debt Does Vir Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vir Biotechnology Have?
    Cash and short term investments quarterly total is $1.5B
  • What Is Vir Biotechnology’s Book Value Per Share?
    Book value per share is 11.80

Is Vir Biotechnology Cash Flow Positive?

  • What Is VIR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$778.8M
  • What Is Vir Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.5M
  • What Is Vir Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $164.6M

Vir Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    VIR return on invested capital is -33.71%
  • What Is Vir Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is -26.34%
  • What Is VIR Return On Equity?
    ROE is a measure of profitability and is -33.71%

Vir Biotechnology Earnings Date & Stock Price

Vir Biotechnology Competitors

  • Who Are Vir Biotechnology's Competitors?
    Below is a list of companies who compete with Vir Biotechnology or are related in some way:
    • SeaStar Medical Holding Corp (ICU)
    • Immuneering Corp (IMRX)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Vertex Pharmaceuticals Inc (VRTX)
    • Vistagen Therapeutics Inc (VTGN)

Vir Biotechnology Dividend Yield

Data Unavailable

Vir Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.96%
Revenue: -55.93% 381.34%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 29.75
Upside from Last Price: 186.33%

Major Shareholders

  • How many VIR shares are owned by institutional investors?
    133.1M VIR shares are owned by institutional investors
  • How many VIR shares are owned by insiders?
    4.7M VIR shares are owned by insiders